BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 69 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $652,286 | +2.7% | 16,661 | +6.6% | 0.00% | +50.0% |
Q2 2023 | $635,375 | +97951.7% | 15,634 | +1.0% | 0.00% | -33.3% |
Q1 2023 | $648 | -13.7% | 15,484 | -10.2% | 0.00% | -25.0% |
Q4 2022 | $751 | -99.9% | 17,241 | -34.1% | 0.00% | -20.0% |
Q3 2022 | $1,015,000 | +530.4% | 26,157 | +587.6% | 0.01% | +400.0% |
Q2 2022 | $161,000 | -3.0% | 3,804 | +4.2% | 0.00% | 0.0% |
Q1 2022 | $166,000 | -6.2% | 3,652 | -0.4% | 0.00% | 0.0% |
Q4 2021 | $177,000 | +7.3% | 3,666 | +5.8% | 0.00% | 0.0% |
Q3 2021 | $165,000 | -4.1% | 3,466 | -2.7% | 0.00% | 0.0% |
Q2 2021 | $172,000 | +14.7% | 3,562 | +9.3% | 0.00% | 0.0% |
Q1 2021 | $150,000 | -3.2% | 3,260 | -0.2% | 0.00% | 0.0% |
Q4 2020 | $155,000 | +10.7% | 3,268 | -0.5% | 0.00% | 0.0% |
Q3 2020 | $140,000 | +32.1% | 3,286 | +26.9% | 0.00% | 0.0% |
Q2 2020 | $106,000 | +43.2% | 2,590 | +26.0% | 0.00% | 0.0% |
Q1 2020 | $74,000 | – | 2,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RENAISSANCE INVESTMENT CONSULTANTS HOLDING COMPANY, LLC | 18,736 | $675,000 | 0.94% |
CORRADO ADVISORS, LLC | 9,565 | $344,000 | 0.32% |
Rikoon Group, LLC | 19,188 | $692,000 | 0.29% |
Eudaimonia Partners, LLC | 4,875 | $176,000 | 0.08% |
Arete Wealth Advisors, LLC | 10,183 | $367,000 | 0.07% |
CENTAURUS FINANCIAL, INC. | 8,465 | $305,000 | 0.06% |
Cetera Advisors LLC | 17,379 | $627,000 | 0.03% |
Jacobi Capital Management LLC | 4,034 | $145,000 | 0.03% |
Financial Advantage, Inc. | 773 | $27,000 | 0.02% |
MID ATLANTIC FINANCIAL MANAGEMENT INC/ADV | 5,868 | $212,000 | 0.02% |